Shuttle Pharmaceuticals Holdings, Inc.
SHPH
$0.45
-$0.03-6.55%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 8.43M | 7.86M | 6.38M | 6.70M | 4.66M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.18M | 11.92M | 10.91M | 11.69M | 9.26M |
| Operating Income | -11.18M | -11.92M | -10.91M | -11.69M | -9.26M |
| Income Before Tax | -10.82M | -11.72M | -10.71M | -12.14M | -10.47M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -10.82 | -11.72 | -10.71 | -12.14 | -10.47 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.82M | -11.72M | -10.71M | -12.14M | -10.47M |
| EBIT | -11.18M | -11.92M | -10.91M | -11.69M | -9.26M |
| EBITDA | -10.89M | -11.63M | -10.90M | -11.69M | -9.26M |
| EPS Basic | -5.71 | -12.88 | -20.06 | -58.84 | -79.67 |
| Normalized Basic EPS | -3.65 | -8.13 | -12.53 | -31.85 | -44.95 |
| EPS Diluted | -5.72 | -12.88 | -21.92 | -60.70 | -81.54 |
| Normalized Diluted EPS | -3.65 | -8.13 | -12.53 | -31.85 | -44.95 |
| Average Basic Shares Outstanding | 11.16M | 6.53M | 3.96M | 1.82M | 778.10K |
| Average Diluted Shares Outstanding | 11.16M | 6.53M | 3.96M | 1.82M | 778.10K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |